Magentiq Eye

Improving Colonoscopy through AI

Health Tech & Life Sciences
Active
Series A Haifa Founded 2014
Total raised
$6.1M
Last: Series A 2025-07
Stage
Series A
Founded
2014
Headcount
26
HQ
Haifa
Sector
Health Tech & Life Sciences

About

Magentiq Eye offers a groundbreaking AI aided colonoscopy solution. The company uses the growing power of deep learning, image processing, and video processing to help doctors become more accurate and effective, potentially saving millions of lives and billions of dollars.

The company’s first product is MAGENTIQ-COLO, which is used to increase adenoma (polyp) detection rates and the overall quality of colonoscopy exams. MAGENTIQ-COLO is a real-time adjunct to the colonoscopy device that points out suspicious locations of polyps in the videos, thereby helping doctors reduce their polyp miss-rates. Given the large population that undergoes colonoscopy annually, even a modest decrease in polyp miss-rates has the potential to save many lives.

MAGENTIQ-COLO has received the CE mark and FDA clearance. It also completed a successful multi-center international clinical trial to attain clearance for marketing in the USA. Its next version includes additional features such as polyp size estimation, polyp characterization, and additional quality measurements.

Funding history · 4 rounds · $6.1M total

2025-07
Series A Undisclosed
2023-12
SAFE $2.0M
2021-07
Seed $1.8M
2018-06
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Artificial IntelligenceDeep LearningComputer VisionPlatforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 PatentsVerified

Tags

medical-devicesimage-processingendoscopyvideocolonoscopyreal-timediagnosticsdata-analyticsgastroenterologydigital-healthcaresoftware-developmentbig-datadecision-supportcanceroptronics